Terms: = Head and neck cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA
54 results:
1. nrg1 promotes tumorigenesis and metastasis and afatinib treatment efficiency is enhanced by nrg1 inhibition in esophageal squamous cell carcinoma.
Hou G; Niu T; Jia A; Zhang Y; Chen X; Wei H; Jia Y; Xu Y; Li Y; Wang P; Chatterjee A
Biochem Pharmacol; 2023 Dec; 218():115920. PubMed ID: 37989416
[TBL] [Abstract] [Full Text] [Related]
2. HER4 and EGFR Activate Cell Signaling in nrg1 Fusion-Driven cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
Udagawa H; Nilsson MB; Robichaux JP; He J; Poteete A; Jiang H; Heeke S; Elamin YY; Shibata Y; Matsumoto S; Yoh K; Okazaki S; Masuko T; Odintsov I; Somwar R; Ladanyi M; Goto K; Heymach JV
J Thorac Oncol; 2024 Jan; 19(1):106-118. PubMed ID: 37678511
[TBL] [Abstract] [Full Text] [Related]
3. Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors.
Garcia-Rendueles MER; Krishnamoorthy G; Saqcena M; Acuña-Ruiz A; Revilla G; de Stanchina E; Knauf JA; Lester R; Xu B; Ghossein RA; Fagin JA
Mol Cancer; 2022 Dec; 21(1):213. PubMed ID: 36476495
[TBL] [Abstract] [Full Text] [Related]
4.
Gong XY; Chen HB; Zhang LQ; Chen DS; Li W; Chen DH; Xu J; Zhou H; Zhao LL; Song YJ; Xiao MZ; Deng WL; Qi C; Wang XR; Chen X
Front Immunol; 2022; 13():920253. PubMed ID: 35911687
[TBL] [Abstract] [Full Text] [Related]
5. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.
Chen N; Golczer G; Ghose S; Lin B; Langenbucher A; Webb J; Bhanot H; Abt NB; Lin D; Varvares M; Sattler M; Egloff AM; Joh R; Uppaluri R; Emerick KS; Lawrence MS; Saladi SV
Cell Rep; 2022 Jun; 39(11):110970. PubMed ID: 35705032
[TBL] [Abstract] [Full Text] [Related]
6. AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
Iida M; McDaniel NK; Kostecki KL; Welke NB; Kranjac CA; Liu P; Longhurst C; Bruce JY; Hong S; Salgia R; Wheeler DL
BMC Cancer; 2022 Apr; 22(1):447. PubMed ID: 35461210
[TBL] [Abstract] [Full Text] [Related]
7. Low-grade non-intestinal-type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity.
Rooper LM; Thompson LDR; Gagan J; Hwang JSG; London NR; Mikula MW; Stevens TM; Bishop JA
Mod Pathol; 2022 Sep; 35(9):1160-1167. PubMed ID: 35322195
[TBL] [Abstract] [Full Text] [Related]
8. Safety and Efficacy of Percutaneous Cryoablation of Extraspinal Thyroid cancer Bone Metastases with Curative Intent: Single-Center Experience with a Median Follow-up of More than 5 Years.
Autrusseau PA; Schneegans O; Koch G; Weiss J; Caudrelier J; Dalili D; Perolat R; Auloge P; Cazzato RL; Gangi A; Garnon J
J Vasc Interv Radiol; 2022 Jul; 33(7):797-804. PubMed ID: 35318124
[TBL] [Abstract] [Full Text] [Related]
9. Non-aspirin NSAIDs and head and neck cancer mortality in a Danish nationwide cohort study.
de la Cour CD; Dehlendorff C; von Buchwald C; Garset-Zamani M; Grønhøj C; Carlander AF; Friis S; Kjaer SK
Cancer Epidemiol; 2022 Apr; 77():102121. PubMed ID: 35183905
[TBL] [Abstract] [Full Text] [Related]
10. A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma.
Li R; Lu C; Yang W; Zhou Y; Zhong J; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Hu H; Lai Y
J Clin Lab Anal; 2022 Feb; 36(2):e24194. PubMed ID: 35028969
[TBL] [Abstract] [Full Text] [Related]
11. RENORT: a project to analyze patterns of care in radiation oncology in Spain.
López-Torrecilla J; Palacios Eito A; Gómez-Caamaño A; Salinas Ramos J; Samper Ots P; Rodríguez Pérez A
Clin Transl Oncol; 2022 Jul; 24(7):1322-1332. PubMed ID: 35028930
[TBL] [Abstract] [Full Text] [Related]
12. Esophageal cancer in relation to alcohol drinking and tobacco use among men in Kerala, India - Karunagappally cohort.
Jayalekshmi PA; Nandakumar A; Nair RA; Akiba S; Koriyama C
Cancer Epidemiol; 2021 Oct; 74():102018. PubMed ID: 34507085
[TBL] [Abstract] [Full Text] [Related]
13. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
[TBL] [Abstract] [Full Text] [Related]
14. Pattern of care in radiotherapy at a University Hospital in Spain: the RENORT project.
López-Torrecilla J; González Sanchis D; Granero Cabañero D; García Miragall E; Almendros Blanco P; Hernandez Machancoses A; Brualla González L; Pastor Peidro J; Gordo Partearroyo JC; Rosello Ferrando J
Clin Transl Oncol; 2021 Aug; 23(8):1657-1665. PubMed ID: 33586123
[TBL] [Abstract] [Full Text] [Related]
15. The Contribution of Genetic Variants to the Risk of Papillary Thyroid Carcinoma in the Kazakh Population: Study of Common Single Nucleotide Polymorphisms and Their Clinicopathological Correlations.
Mussazhanova Z; Rogounovitch TI; Saenko VA; Krykpayeva A; Espenbetova M; Azizov B; Kondo H; Matsuda K; Kalmatayeva Z; Issayeva R; Yeleubayeva Z; Madiyeva M; Mukanova A; Sandybayev M; Bolsynbekova S; Kozykenova Z; Yamashita S; Nakashima M
Front Endocrinol (Lausanne); 2020; 11():543500. PubMed ID: 33551988
[TBL] [Abstract] [Full Text] [Related]
16. Using the Patient Concerns Inventory in the identification of fatigue following treatment for head and neck cancer.
Rogers SN; Semple CJ; Humphris GM; Lowe D; Kanatas A
Int J Oral Maxillofac Surg; 2021 Jul; 50(7):865-872. PubMed ID: 33250271
[TBL] [Abstract] [Full Text] [Related]
17. Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database.
Zhao XT; Zhu Y; Zhou JF; Gao YJ; Liu FZ
Oral Oncol; 2021 Jan; 112():105088. PubMed ID: 33220636
[TBL] [Abstract] [Full Text] [Related]
18. Applying nomograms based on the surveillance, epidemiology and end results database to predict long-term overall survival and cancer-specific survival in patients with oropharyngeal squamous cell carcinomas: A case-control research.
Wang F; Wen J; Yang X; Jia T; Du F; Wei J
Medicine (Baltimore); 2020 Jul; 99(30):e20703. PubMed ID: 32791664
[TBL] [Abstract] [Full Text] [Related]
19. Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in head and neck Squamous Cell Carcinoma Patients.
Duvvuri U; George J; Kim S; Alvarado D; Neumeister VM; Chenna A; Gedrich R; Hawthorne T; LaVallee T; Grandis JR; Bauman JE
Clin Cancer Res; 2019 Oct; 25(19):5752-5758. PubMed ID: 31308059
[TBL] [Abstract] [Full Text] [Related]
20. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study.
de la Cour CD; Dehlendorff C; Aalborg GL; von Buchwald C; Friis S; Verdoodt F; Kjaer SK
Int J Cancer; 2020 Apr; 146(8):2139-2146. PubMed ID: 31265123
[TBL] [Abstract] [Full Text] [Related]
[Next]
